Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Biocon Limited
Press Release Jul 16 2025
Business
Jul 16 2025
5 min read

Press Release Jul 16 2025

Biocon Limited has informed the Exchange regarding a press release dated July 15, 2025, titled "Biocon Biologics Expands Diabetes Portfolio with FDA Approvalof Kirsty , the First and Only Interchangeable Rapid-ActingInsulin Aspart in the United States".

View Attachment